Related Experiment Video
Updated: Jun 13, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Hypertriglyceridemia‑Induced Acute Pancreatitis Compared With Non-Hypertriglyceridemia Acute Pancreatitis: A
Zahra Farhangiyan1,2, Leila Moradi1,2, Mehrdad Vaziri1
1Department of Internal Medicine, School of Medicine Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
Hypertriglyceridemia-induced acute pancreatitis (HTGAP) leads to more severe disease and higher complication rates compared to other forms of acute pancreatitis (AP). Early recognition and management are crucial for better patient outcomes.
Area of Science:
- Gastroenterology
- Internal Medicine
- Clinical Research
Background:
- Hypertriglyceridemia-induced acute pancreatitis (HTGAP) is a distinct subtype of acute pancreatitis (AP).
- Comparative data on risk factors, disease severity, and outcomes between HTGAP and non-HTGAP are limited.
- Understanding these differences is crucial for effective clinical management.
Purpose of the Study:
- To compare the risk factors, disease severity, and clinical outcomes of patients with HTGAP versus non-HTGAP.
- To identify specific characteristics associated with HTGAP.
- To inform clinical practice regarding the management of severe pancreatitis.
Main Methods:
- A retrospective case-control study was conducted at a single center.
- 150 patients with HTGAP and 150 patients with non-HTGAP were included.
- Demographic data, severity scores (Ranson, APACHE II, MCTSI), complications, and length of hospital stay were compared.
Main Results:
- HTGAP patients were younger, had higher BMI, and experienced significantly more complications (e.g., ARDS, sepsis, pancreatic necrosis, renal failure).
- HTGAP was associated with higher severity scores (Ranson, APACHE II, MCTSI) and longer hospital stays.
- No in-hospital mortality was observed in either group during the study period.
Conclusions:
- HTGAP presents with a more severe clinical profile and increased complication rates compared to non-HTGAP.
- Early identification and prompt management strategies are essential for patients with HTGAP.
- Limitations include the retrospective, single-center design and lack of multivariable analysis.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...